Marina Acosta Enslen

Senior Director, Clinical Operations

Marina Acosta Enslen

Senior Director, Clinical Operations

Marina Acosta Enslen has been involved in the conduct of clinical trials for 20 years, working in academia, pharmaceutical, and CRO markets. She has experience working on NIH and industry funded Phase 1 – 4 global clinical trials. Much of her career has been focused in infectious disease, primarily HIV/AIDS and HPV research providing clinical trial coordination, monitoring and clinical team leadership. Ms. Acosta Enslen’s broad experience from multiple perspectives and strong understanding of clinical trial management particular to infectious disease trials has allowed her to successfully lead teams.

Prior to joining Rho, Ms. Acosta Enslen’s experience included the conduct of 14 global infectious disease trials resulting in the approval of three new HIV medications and 2 new classes of antivirals. In addition to novel HIV therapies, Ms. Acosta Enslen has worked on combination ARV therapies, HIV and Hep C co-morbidity studies, HPV and HIV vaccine studies, and observational studies focused on the reduction of common ARV treatment complications such as lipodystrophy and cardiovascular disease. Her extensive experience provides Ms Acosta Enslen unique insight into the operations of both regional and global infectious disease clinical trials.

In addition to her infectious disease experience, Ms. Acosta Enslen has experience in the conduct of clinical trials in the therapeutic areas of oncology, gastroenterology, cardiology, urology, and nephrology.

Ms. Acosta Enslen earned her undergraduate degree in Psychology with a concentration in research methodology.

This is what drives Marina:

“I’m passionate about the impact this work can have on patients. In my 20 years in the industry, I have witnessed incredible progress in the treatment of HIV. Today, HIV positive patients have a higher quality of life (including a low pill burden) and a much longer life expectancy than they did 20 years ago.”


Content by Marina Acosta Enslen

Rho_Resource_Webinar
Webinar

Partnering for Success: Doing Study Start-Up Right in the Context of Decentralized Studies

Study start-up sets the foundation for success of your clinical trial. There are many considerations for vendor selection and partnerships during development and start-up. With these come challenges: complex protocols, gaps in site expectations, problems with enrollment and retention, etc. To combat these challenges and improve the chance for success there are several important concepts to keep in mind in the context of decentralized trials.

Rho_Resource_Webinar
Webinar

Mitigating Covid-19 through a Hybrid Decentralized Clinical Trials Approach

The Covid-19 pandemic has presented the industry with many risks and challenges to the management of clinical trials. For many, the mitigation of these issues has accelerated the implementation of decentralized approaches to monitoring and management of clinical trials. In this webinar, we will discuss:
what risks and challenges COVID-19 has presented, ways in which these can be addressed, and
Rho as a case study.

Marina Acosta
Blog Post

Considerations for Implementing Decentralized Clinical Trials

The COVID-19 pandemic has accelerated the implementation of decentralized (also referred to as virtual, remote, or hybrid) solutions for clinical trials. In addition to keeping your clinical trials on-track during the pandemic, decentralized solutions can often provide added benefits, including an improved patient experience by increasing engagement and reducing patient burden. We will discuss some considerations for successfully implementing decentralized solutions.

Rho_Resource_Webinar
Webinar

Managing the Risks of Implementing E6R2

Successful implementation of RBQM is a challenge many in our industry are facing. To understand what it is and how it impacts the management of your clinical trial, this webinar will address what exactly E6R2 is. We will use Rho as a case study for designing and implementing a strategy, discuss common misconceptions, and review lessons Rho has learned through implementation of RBQM.

Rho_Resource_Webinar
Webinar

Challenges with Fast Enrolling Post-Operative Acute Pain Studies

There are a lot of resources on how to deal with slow enrolling studies, but what about challenges with studies that enroll very quickly?  Enrollment can be very fast for post-operative acute pain studies which brings with it unique challenges in study execution.